Octapharma to present clinical and scientific data that advances our understanding and treatment of bleeding disorders at the 17th Annual Congress of the European Association for Haemophilia and Allied Disorders , which takes place in Frankfurt, Ge

Octapharma AG Italy Netherlands Switzerland Brazil China Japan

Octapharma will present new clinical and scientific findings for wilate® and Nuwiq®New findings in von Willebrand disease (VWD) and haemophilia A, will be presented by leading experts in a Satellite Symposium, as well as an oral and six poster presentationsPresentations will include new data on the efficacy and safety of wilate® prophylaxis in people with von Willebrand disease (VWD)View original content:https://www.prnewswire.co.uk/news-releases/octapharma-to-present-clinical-and-scientific-data-that-advances-our-understanding-and-treatment-of-bleeding-disorders-at-the-17th-annual-congress-of-the-european-association-for-haemophilia-and-allied-disorders-eahad-which-tak-302037372.html